Molecular superglue, also called as flesh-eating bacteria, is used to hold proteins or stick them immovably to surfaces. It is even used to assemble proteins and enzymes to build new structures on a nanometer scale. Molecular superglue was discovered by Dr. Howarth and Zakeri at the Department of Biochemistry of the University of Oxford. They developed an adhesive that binds molecules together and forms a disease-fighting agent. It is a gel made of cyanoacrylates, which helps in developing a rapidly acting adhesive.
The term ‘cyanoacrylate glue’ generally describes quick-bonding superglue. The glue can be used to join objects ranging from metals to plastics and even the human skin. Unlike the traditional adhesives that are water-based, cyanoacrylate glue is composed of acrylic resins. Its key ingredient is cyanoacrylate, which is an acrylic monomer that transforms into a plastic state after curing. By using cyanoacrylate glue, proteins are locked together in such a manner that they can support better diagnostic tests, for instance, early detection of the cancer cells circulating in the blood. In research, cyanoacrylate glue is also employed for examining how forces inside the cells change the biochemistry of human’s body and affect the patient’s health.
Molecular superglue market is undergoing technological advancements. Companies are striving to develop new and better methods to manufacture these molecular superglues. Development of new processes for the manufacture of molecular superglue and rise in its utilization are expected to propel the molecular superglue market during the forecast period. For instance, over the last few years, a Denmark-based research group has developed a new nanotechnology that optimizes the adhesion between plastic and metal on a molecular level (basically, a molecular superglue).